EDAP TMS S.A. (ADR) (NASDAQ:EDAP)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development, production, marketing, distribution and maintenance of a portfolio of minimally-invasive medical devices for the treatment of urological diseases.

Results 1 - 5 of 5

Recs

0
Member Avatar clangmead (< 20) Submitted: 1/13/2016 6:39:28 AM : Outperform Start Price: $3.31 EDAP Score: +11.07

mtsi

Recs

0
Member Avatar Fiskhus (68.87) Submitted: 10/3/2015 6:01:27 PM : Outperform Start Price: $4.60 EDAP Score: -17.78

FinViz10/3

Recs

0
Member Avatar Downeastah (27.67) Submitted: 6/19/2011 5:02:32 PM : Outperform Start Price: $3.07 EDAP Score: -31.66

A SAFER APPROACH TO A CANCER PROBLEM THAT HAS BEEN AROUND FOR YEARS AND THAT HAS BEEN TREATED WITH NUMEROUS, OLDER METHODS. AND NOW WE HAVE EDAP'S PROVEN TECHNOLOGY.

Recs

0
Member Avatar hoperalot1 (< 20) Submitted: 12/17/2010 3:27:43 PM : Outperform Start Price: $2.16 EDAP Score: -16.72

Get it while you can!!. Edap has product and procedure to reach 20+

Recs

0
Member Avatar geo11zak (28.85) Submitted: 12/16/2010 8:14:47 AM : Outperform Start Price: $4.89 EDAP Score: -77.21

valuation, great product ,

Results 1 - 5 of 5

Featured Broker Partners